According to previous reports, the reduction in SPRY2 levels in hepatoma cells promotes the proliferation and migration of hepatoma cells, and the decrease in SPRY2 levels in macrophages leads to the polarization of macrophages toward the M2 phenotype (39). Here, SPRY2 is linked to hepatocellular carcinoma.